AAAAAA
Results:
1-23
|
Results: 23
Authors:
AGELINK MW
DIRKESKERSTING A
ZEIT T
BERTLING R
MALESSA R
KLIESER E
Citation: Mw. Agelink et al., SENSITIVITY OF CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) IN RELATION TO AGE AND DURATION OF ABSTINENCE, Alcohol and alcoholism, 33(2), 1998, pp. 164-167
Authors:
AGELINK MW
MALESSA R
KAMCILI E
ZEIT T
LEMMER W
BERTLING R
KLIESER E
Citation: Mw. Agelink et al., CARDIOVASCULAR AUTONOMIC REACTIVITY IN SCHIZOPHRENICS UNDER NEUROLEPTIC TREATMENT - A POTENTIAL PREDICTOR OF SHORT-TERM OUTCOME, Neuropsychobiology, 38(1), 1998, pp. 19-24
Authors:
AGELINK MM
ZEIT T
KLIESER E
Citation: Mm. Agelink et al., PROLONGED BRADYCARDIA COMPLICATES ANTIDEPRESSIVE TREATMENT WITH VENLAFAXINE AND ECT, British Journal of Psychiatry, 173, 1998, pp. 441-441
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
Citation: C. Wurthmann et al., SIDE-EFFECTS OF LOW-DOSE NEUROLEPTICS AND THEIR IMPACT ON CLINICAL OUTCOME IN GENERALIZED ANXIETY DISORDER, Progress in neuro-psychopharmacology & biological psychiatry, 21(4), 1997, pp. 601-609
Authors:
LEHMANN E
KLIESER E
Citation: E. Lehmann et E. Klieser, DRUG-MONITORING STUDIES AS A METHOD OF ANALYZING RESPONSE CRITERIA, Pharmacopsychiatry, 30, 1997, pp. 52-56
Authors:
SMALL JG
HIRSCH SR
ARVANITIS LA
MILLER BG
LINK CGG
MURPHY AL
BOWDEN CL
OBRIEN CP
STEINBOOK RM
WAGNER RL
PITTS WM
CRABTREE B
CORRIGAN MHN
LOHR JB
MILLER AL
ERESHEFSKY L
ANDERSON CB
KNESEVICH MA
ROTROSEN J
OWEN RR
KARSON CN
LINDENMAYER JP
PFEFFERBAUM A
FAUSTMAN WO
KECK PE
PATTERSON WM
RIESENBERG RA
GLADSON MB
KOLIN IS
BARNES TRE
SENSKY T
RICCIO M
FRANKS S
JOLLEY A
HALLSTROM C
BENNIE E
DARCOURT G
PATRIS M
DESILVA M
PATEL AG
FLEISCHHACKER WW
DIETZEL M
SEIFERTOVA D
VINAR O
FALTUS F
BITTER I
OZSVATH K
SHAW SH
MAHAPATRA SN
SZULECKA TK
SUNDARARAJAN K
CREAVEN F
LYNCH J
KLIESER E
COOPER SJ
ASCHAUER H
Citation: Jg. Small et al., QUETIAPINE IN PATIENTS WITH SCHIZOPHRENIA - A HIGH-DOSE AND LOW-DOSE DOUBLE-BLIND COMPARISON WITH PLACEBO, Archives of general psychiatry, 54(6), 1997, pp. 549-557
Authors:
AGELINK MW
ZITZELSBERGER A
KLIESER E
Citation: Mw. Agelink et al., WITHDRAWAL SYNDROME AFTER DISCONTINUATION OF VENLAFAXINE, The American journal of psychiatry, 154(10), 1997, pp. 1473-1474
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
KRAUTH J
Citation: C. Wurthmann et al., SINGLE-SUBJECT EXPERIMENTS TO DETERMINE INDIVIDUALLY DIFFERENTIAL-EFFECTS OF ANXIOLYTICS IN GENERALIZED ANXIETY DISORDER, Neuropsychobiology, 33(4), 1996, pp. 196-201
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
Citation: C. Wurthmann et al., DIFFERENTIAL THERAPY IN GENERALIZED ANXIE TY DISORDERS - 30 SINGLE-CASE EXPERIMENTS, Fortschritte der Neurologie, Psychiatrie, 63(8), 1995, pp. 303-309
Authors:
KLIMKE A
KLIESER E
Citation: A. Klimke et E. Klieser, THE ATYPICAL NEUROLEPTIC CLOZAPINE (LEPON EX(R)) - STATE-OF-THE-ART AND RECENT CLINICAL ASPECTS, Fortschritte der Neurologie, Psychiatrie, 63(5), 1995, pp. 173-193
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
Citation: C. Wurthmann et al., INTERACTION OF THERAPEUTIC EFFECTS AND SI DE-EFFECTS IN PHARMACOTHERAPY OF GENERALIZED ANXIETY DISORDERS WITH LOW-DOSAGE FLUSPIRILENE, Fortschritte der Neurologie, Psychiatrie, 63(2), 1995, pp. 72-77
Authors:
FALKAI P
SCHNEIDER T
GREVE B
KLIESER E
BOGERTS B
Citation: P. Falkai et al., REDUCED FRONTAL AND OCCIPITAL LOBE ASYMMETRY ON THE CT-SCANS OF SCHIZOPHRENIC-PATIENTS - ITS SPECIFICITY AND CLINICAL-SIGNIFICANCE, Journal of neural transmission, 99(1-3), 1995, pp. 63-77
Authors:
WURTHMANN C
KLIESER E
LEHMANN E
PESTER U
Citation: C. Wurthmann et al., TEST THERAPY IN THE TREATMENT OF GENERALIZED ANXIETY DISORDERS WITH LOW-DOSE FLUSPIRILENE, Progress in neuro-psychopharmacology & biological psychiatry, 19(6), 1995, pp. 1049-1060
Authors:
KLIESER E
LEHMANN E
KINZLER E
WURTHMANN C
HEINRICH K
Citation: E. Klieser et al., RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF RISPERIDONE VERSUS CLOZAPINE IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA, Journal of clinical psychopharmacology, 15(1), 1995, pp. 45-51
Authors:
KLIESER E
LEHMANN E
HEINRICH K
Citation: E. Klieser et al., FLUOXETINE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER - A RESPONDER ANALYSIS, Pharmacopsychiatry, 28(1), 1995, pp. 14-19
Authors:
WOITALLA D
KLIESER E
Citation: D. Woitalla et E. Klieser, PSYCHIATRIC ILLNESSES WITH POSTPARTUM ONS ET, Der Gynakologe, 28(6), 1995, pp. 434-439
Authors:
KLIMKE A
KLIESER E
Citation: A. Klimke et E. Klieser, CATATONIA - CURRENT THERAPEUTIC RECOMMENDATIONS, CNS DRUGS, 2(4), 1994, pp. 280-291
Authors:
STRAUSS WH
KLIESER E
Citation: Wh. Strauss et E. Klieser, EARLY ASSESSMENT OF SYMPTOMS IN SCHIZOPHRENICS, Schizophrenia research, 11(2), 1994, pp. 179-179
Authors:
HEINRICH K
KLIESER E
LEHMANN E
KINZLER E
HRUSCHKA H
Citation: K. Heinrich et al., RISPERIDONE VERSUS CLOZAPINE IN THE TREATMENT OF SCHIZOPHRENIC-PATIENTS WITH ACUTE SYMPTOMS - A DOUBLE-BLIND, RANDOMIZED TRIAL, Progress in neuro-psychopharmacology & biological psychiatry, 18(1), 1994, pp. 129-137
Authors:
KLIMKE A
KLIESER E
Citation: A. Klimke et E. Klieser, SUDDEN-DEATH AFTER INTRAVENOUS APPLICATION OF LORAZEPAM IN A PATIENT TREATED WITH CLOZAPINE, The American journal of psychiatry, 151(5), 1994, pp. 780-780
Authors:
KLIESER E
STRAUSS WH
LEMMER W
Citation: E. Klieser et al., THE TOLERABILITY AND EFFICACY OF THE ATYPICAL NEUROLEPTIC REMOXIPRIDECOMPARED WITH CLOZAPINE AND HALOPERIDOL IN ACUTE SCHIZOPHRENIA, Acta psychiatrica Scandinavica, 89, 1994, pp. 68-73
Authors:
KLIMKE A
KLIESER E
STRAUSS WH
Citation: A. Klimke et al., COGNITIVE AND AFFECTIVE SIDE-EFFECTS DURING TREATMENT OF ACUTE SCHIZOPHRENIA WITH CLASSICAL VERSUS ATYPICAL NEUROLEPTICS, Neuropsychopharmacology, 9(2), 1993, pp. 190000116-190000117
Authors:
KLIMKE A
KLIESER E
Citation: A. Klimke et E. Klieser, THE CLINICAL INCIDENCE OF DRUG-INDUCED SIDE-EFFECTS DURING CLOZAPINE THERAPY IN COMBINATION WITH OTHER PSYCHOTROPIC-DRUGS, Neuropsychopharmacology, 9(2), 1993, pp. 190000116-190000116
Risultati:
1-23
|